Podcast Friday: Sex After Cancer, New Cystic Fibrosis Drug
In this week’s podcast, audio versions of two recent CommonHealth hits:
Sex After Cancer: Among the nearly 12 million cancer survivors in the U.S., many suffer from sexual problems related to their cancer of the treatment to fight it. Rachel Zimmerman details the problems, talks to patients and tracks one psychologist’s efforts to bring pleasure back to patients.
New Drug For Cystic Fibrosis: A still-experimental drug, called VX-770, while not a cure, is being called a “major advance” in CF research. VX-770 attacks the basic defect in cystic fibrosis, and right now helps only 4 percent of those living with cystic fibrosis. Carey Goldberg explains what VX-770 does, and how it’s helped one woman do things she’s never done before — like shovel snow.